Evidence map›Paper›PMID 37324420›Full record

ArticleFrontiers in bioengineering and biotechnology2023

A specific H

Grégoire B L Henry, Florent Awedem Wobiwo, Arnaud Isenborghs, Thomas Nicolay, Bruno Godin, Benoit A Stenuit, Patrick A Gerin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Grégoire B L HenryLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Florent Awedem WobiwoLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Arnaud IsenborghsLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Thomas NicolayLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Bruno GodinWalloon Agricultural Research Center (CRA-W), Valorization of Agricultural Products Department, Gembloux, Belgium.
Benoit A StenuitLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
Patrick A GerinLaboratory of Bioengineering and Biorefining, Earth and Life Institute-Applied Microbiology, Université Catholique de Louvain, Louvain-La-Neuve, Belgium.
UCLouvain · BEWalloon Agricultural Research Centre · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brewer's spent grain (BSG) is an undervalorized organic feedstock residue composed of fermentable macromolecules, such as proteins, starch, and residual soluble carbohydrates. It also contains at least 50% (as dry weight) of lignocellulose. Methane-arrested anaerobic digestion is one of the promising microbial technologies to valorize such complex organic feedstock into value-added metabolic intermediates, such as ethanol, H

Indexed as

acidogenic fermentationcomplex organic feedstockH2/CO2 conversionmedium-chain carboxylatesmethane-arrested anaerobic digestionreverse β-oxidationWood-Ljungdahl pathway

Identifiers

PMID37324420
PMCPMC10267453
OpenAlexW4379056610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.